Cargando…
Current status of newborn screening for Pompe disease in Japan
BACKGROUND: Pompe disease is an autosomal recessive inherited metabolic disorder caused by a deficiency of the acid α-glucosidase (GAA). Pompe disease manifests as an accumulation of lysosomal glycogen in the skeletal and heart muscle. We conducted newborn screening (NBS) for Pompe disease in Japan...
Autores principales: | Sawada, Takaaki, Kido, Jun, Sugawara, Keishin, Momosaki, Ken, Yoshida, Shinichiro, Kojima-Ishii, Kanako, Inoue, Takahito, Matsumoto, Shirou, Endo, Fumio, Ohga, Shouichi, Hirose, Shinichi, Nakamura, Kimitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684119/ https://www.ncbi.nlm.nih.gov/pubmed/34922579 http://dx.doi.org/10.1186/s13023-021-02146-z |
Ejemplares similares
-
Newborn screening for Fabry disease in the western region of Japan
por: Sawada, Takaaki, et al.
Publicado: (2020) -
Newborn screening for Gaucher disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2022) -
Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan
por: Hattori, Yusuke, et al.
Publicado: (2023) -
Fabry disease screening in high-risk populations in Japan: a nationwide study
por: Yoshida, Shinichiro, et al.
Publicado: (2020) -
Detection of novel Fabry disease‐associated pathogenic variants in Japanese patients by newborn and high‐risk screening
por: Sawada, Takaaki, et al.
Publicado: (2020)